+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Central Nervous System Generics"

Generic Central Nervous System Drugs Global Market Report 2024 - Product Thumbnail Image

Generic Central Nervous System Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

The Central Nervous System (CNS) Generics market is a subset of the larger Central Nervous System Drugs market. CNS Generics are generic versions of brand-name drugs used to treat neurological disorders, such as epilepsy, Parkinson's disease, and Alzheimer's disease. These drugs are typically cheaper than their brand-name counterparts, making them more accessible to patients. CNS Generics are also used to treat a variety of other conditions, such as depression, anxiety, and insomnia. CNS Generics are typically manufactured by generic drug companies, which specialize in producing generic versions of brand-name drugs. These companies often have extensive research and development capabilities, allowing them to develop new drugs and improve existing ones. Additionally, generic drug companies often have strong relationships with healthcare providers, allowing them to provide better access to their products. Some of the major companies in the CNS Generics market include Teva Pharmaceuticals, Mylan, Sun Pharmaceuticals, and Dr. Reddy's Laboratories. These companies are all major players in the global generics market, and have a strong presence in the CNS Generics market. Show Less Read more